← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Murdoch Children'S Research Institute
Melbourne
$9,581,584
Total funding
14
Grants
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,808,927 · 8
DOD$3,772,657 · 6
By mechanism
—$3,772,657 · 6
R01$3,762,949 · 4
UH3$1,037,722 · 1
UH2$691,377 · 1
R21$271,879 · 1
N02$45,000 · 1
Investigators at Murdoch Children'S Research Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SOLVING THE UNSOLVED. INTEGRATING OMIC APPROACHES TO ENABLE GENOMIC DIAGNOSIS OF VIRTUALLY ALL PATIENTS WITH MITOCHONDRIAL DISEASE$1,316,596
· FY2018 · Defense Health Agency
BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1$697,766
· FY2024 · Defense Health Agency
THE EMERGENCE OF AUTISM AND ATYPICAL SOCIAL FUNCTIONING IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1: FROM TODDLERHOOD TO EARLY ADOLESCENCE$669,542
· FY2015 · Department of the Army
USING PATIENT-DERIVED STEM CELL MODELS TO DETERMINE THE MOLECULAR MECHANISMS DRIVING NF1-ASSOCIATED NEURODEVELOPMENTAL DISORDERS$494,851
· FY2025 · Defense Health Agency
The safety of pneumococcal polysaccharide vaccine in children - a followup study.$491,637
R01 · FY2010 · AI
Assays for acceleration: from fit-for-purpose models to scalable assays of broad systemic and mucosal protection against all strains of Group A Streptococcus$486,469
R01 · FY2024 · AI
Assays for acceleration: from fit-for-purpose models to scalable assays of broad systemic and mucosal protection against all strains of Group A Streptococcus$486,137
R01 · FY2025 · AI
GENETIC AND EPIGENETIC PREDICTORS OF DEVELOPMENT, PERSISTENCE, AND REMISSION OF SENSITIZATION AND FOOD ALLERGY IN A PROSPECTIVE INFANT COHORT$485,925
· FY2010 · Department of the Army
Assays for acceleration: from fit-for-purpose models to scalable assays of broad systemic and mucosal protection against all strains of Group A Streptococcus$472,269
R01 · FY2023 · AI
The safety of pneumococcal polysaccharide vaccine in children - a followup study.$444,018
R01 · FY2011 · AI
Generating kidney organoids and mature renal cell types via directed iPSC differentiation$346,000
UH3 · FY2017 · DK
Generating kidney organoids and mature renal cell types via directed iPSC differentiation$346,000
UH3 · FY2018 · DK
Generating kidney organoids and mature renal cell types via directed iPSC differentiation$345,777
UH2 · FY2016 · DK
Generating kidney organoids and mature renal cell types via directed iPSC differentiation$345,722
UH3 · FY2019 · DK
Generating kidney organoids and mature renal cell types via directed iPSC differentiation$345,600
UH2 · FY2015 · DK
Genetics of Mild Hearing Loss in children Aged 6-12 yrs$269,702
R01 · FY2003 · DC
Genetics of Mild Hearing Loss in children Aged 6-12 yrs$206,335
R01 · FY2002 · DC
ANALYSIS AND MANIPULATION OF HUMAN NEOCENTROMERES$205,200
R01 · FY2004 · GM
ANALYSIS AND MANIPULATION OF HUMAN NEOCENTROMERES$205,200
R01 · FY2003 · GM
ANALYSIS AND MANIPULATION OF HUMAN NEOCENTROMERES$205,200
R01 · FY2005 · GM